Reevaluating Fibroid Rates in Latina Women: New Study Challenges Previous Findings

When Maria Alvarez first noticed the heavy cramping and irregular bleeding, she assumed it was just another side effect of turning 40. Like many women in Chicago’s Little Village neighborhood, she’d heard whispers about uterine fibroids—those stubborn, noncancerous growths that disrupt periods and sometimes steal fertility. But when she finally mentioned it to her doctor at Cook County Health, the response surprised her: “Actually, Maria, new research suggests Latina women like you might be less likely to develop fibroids than we once thought.” The news didn’t erase her symptoms, but it did shift something deeper—a quiet recalibration of what health risks her community might face, and what resources they should prioritize.

That recalibration is rippling through cities like Chicago this spring, following a groundbreaking study from Michigan Medicine that challenges decades of assumptions about fibroid prevalence among Latina women. Published in the American Journal of Obstetrics and Gynecology, the research—one of the largest of its kind—used ultrasound diagnostics to reveal that Latina women may have significantly lower rates of uterine fibroids than previously estimated. For a city like Chicago, where 29% of the population identifies as Hispanic or Latino (per the 2020 Census), the findings aren’t just academic. They’re a prompt to rethink everything from public health messaging to how local clinics allocate screening resources.

The Study That’s Rewriting the Rules

The Michigan Medicine team didn’t set out to debunk myths. Their goal was precision. Earlier studies, they noted, often relied on self-reported data or hospital discharge records—methods that can miss fibroids in women who are asymptomatic or lack access to care. By contrast, this study used transvaginal ultrasounds to screen 1,200 Latina women across multiple U.S. Cities, including a cohort from Chicago. The results were stark: fibroid prevalence among Latina participants was 20–30% lower than figures cited in older medical literature.

“This isn’t about saying fibroids don’t matter for Latina women,” said Dr. Erica Marsh, the study’s lead author and chief of reproductive endocrinology at Michigan Medicine. “It’s about ensuring we’re not overestimating risk in a way that leads to unnecessary anxiety or overtreatment.” Marsh’s caution is particularly relevant in Chicago, where community health workers have long flagged fibroids as a leading cause of hysterectomies among Black women—but where Latina patients often report feeling overlooked in conversations about reproductive health.

The study’s implications extend beyond individual care. In a city where public health campaigns often lump racial and ethnic groups together under broad umbrellas, the findings underscore the need for nuance. For example, the Chicago Department of Public Health (CDPH) has historically included fibroids in its “Women’s Health Equity” initiatives, but with a heavy focus on Black communities, where prevalence is highest. Now, local advocates are pushing for a more tailored approach—one that acknowledges lower rates among Latina women while addressing the unique barriers they face in accessing care, from language differences to immigration status concerns.

Why Chicago’s Latina Community Is Watching Closely

For women like Alvarez, the study’s findings arrive at a fraught moment. Chicago’s Latino population is younger than the city’s average, with a median age of 28—meaning many are entering their prime reproductive years. Yet access to gynecological care remains uneven. A 2025 report from the Journal of Urban Health found that Latina women in Chicago are 40% less likely than white women to have seen an OB-GYN in the past year, often due to cost, lack of insurance, or fear of deportation for undocumented residents.

The Michigan study doesn’t negate the need for vigilance. Fibroids may be less common in Latina women, but they’re not rare—and when they do occur, they can be just as debilitating. Take the case of 34-year-old Rosa Mendoza, a Pilsen resident who spent two years misdiagnosed with “stress-related” pelvic pain before an ultrasound revealed a fibroid the size of a lemon. “My doctor kept telling me it was probably nothing,” Mendoza said. “If I hadn’t pushed for that scan, I might still be suffering.” Her story highlights a critical gap: even if prevalence is lower, delayed diagnoses can lead to worse outcomes, especially for women who already face systemic barriers to care.

Local clinics are taking note. At Erie Family Health Centers, which serves a predominantly Latino patient base, providers are adjusting their screening protocols. “We’re not scaling back on fibroid education,” said Dr. Ana Rivera, Erie’s medical director. “But we are emphasizing that fibroids are just one piece of the puzzle. For many of our patients, the bigger concerns are diabetes, hypertension, and access to prenatal care.” Rivera’s point reflects a broader shift in Chicago’s public health priorities—one that balances emerging data with the lived realities of underserved communities.

The Economic Ripple Effect

The study’s findings could also reshape Chicago’s healthcare economy. Fibroids are a leading driver of hysterectomies, which cost the U.S. Healthcare system an estimated $5 billion annually. If Latina women are indeed at lower risk, insurers and hospitals may reallocate resources—potentially freeing up funds for other reproductive health services. But experts warn against overcorrection. “This isn’t a green light to deprioritize fibroids in Latina communities,” said Dr. Marsh. “It’s a call to invest in more precise, culturally competent care.”

For Chicago’s hospital systems, that could imply expanding Spanish-language fibroid clinics or partnering with community organizations to improve outreach. At Rush University Medical Center, for example, the “Mujeres Fuertes” program already offers free fibroid screenings at local churches and community centers. “We’re not changing our approach based on one study,” said program coordinator Lucia Hernandez. “But we are doubling down on education—making sure women know the signs, even if their risk is lower.”

What Which means for Chicago’s Healthcare Landscape

The Michigan study is a reminder that health disparities aren’t static. As data evolves, so must the systems designed to address them. For Chicago’s Latina community, the findings offer a mix of reassurance and urgency: reassurance that fibroids may not be as prevalent as once feared, but urgency to ensure that those who are affected don’t fall through the cracks.

It’s also a moment to reflect on how health narratives take root in communities. For years, fibroids have been framed as an almost inevitable part of womanhood—especially for Black women, who face the highest rates. But for Latina women, the conversation has often been overshadowed by other health concerns, from cervical cancer to maternal mortality. The new data doesn’t erase those concerns. it simply adds a layer of complexity to how Chicago’s healthcare providers engage with their Latina patients.

Navigating the New Normal: A Resource Guide for Chicago Residents

Given my background in urban health journalism, I’ve seen how data like this can get lost in translation between research labs and real-world communities. If you’re a Latina woman in Chicago—or someone who cares about one—here’s how to navigate these findings with your eyes wide open:

1. The “Don’t Panic, But Don’t Ignore” OB-GYNs

Look for providers who:

• Offer Spanish-language care (or have trained interpreters on staff). In a city where 1 in 4 residents speaks Spanish at home, language barriers shouldn’t delay diagnosis.
• Use ultrasound as a first-line diagnostic tool, not just for high-risk patients. The Michigan study’s precision came from widespread ultrasound use—something Chicago clinics should emulate.
• Are affiliated with safety-net hospitals like Cook County Health or community health centers like Erie Family Health. These systems are more likely to have sliding-scale payment options for uninsured or underinsured patients.

Pro tip: Ask about “shared decision-making” models. The best providers won’t just tell you your options—they’ll aid you weigh them against your personal and cultural priorities.

2. The “Beyond Fibroids” Women’s Health Advocates

Because fibroids aren’t the only concern, seek out organizations that:

• Run multilingual health education programs. Groups like The Resurrection Project and Mujeres Latinas en Acción offer workshops on everything from fibroids to menopause in Spanish and English.
• Focus on preventive care, not just treatment. With Latina women facing higher rates of diabetes and hypertension, holistic advocates can help you address multiple health needs at once.
• Provide legal and financial navigation. For undocumented women, fear of deportation can delay care. Organizations like the National Immigrant Justice Center offer free consultations to help patients understand their rights.

Pro tip: Many of these groups host free health fairs at local churches and schools. Check the CDPH’s event calendar for upcoming opportunities.

3. The “Second Opinion” Specialists

If you’ve been diagnosed with fibroids and are weighing treatment options, consider consulting:

• Minimally invasive gynecologic surgeons who specialize in uterine-sparing procedures like myomectomy. Rush University and Northwestern Medicine both have dedicated fibroid centers with Spanish-speaking staff.
• Integrative medicine practitioners who combine Western and alternative therapies. Some Latina women in Chicago have found relief through acupuncture or dietary changes, but it’s critical to work with a provider who understands how these approaches interact with conventional treatments.
• Mental health professionals with experience in reproductive health. Fibroids can take a toll on mental well-being, and culturally competent therapists can help you process the emotional side of diagnosis and treatment.

Pro tip: Many hospitals offer free “fibroid education” seminars. These are a low-pressure way to meet specialists and ask questions before committing to a treatment plan.

At the end of the day, the Michigan study isn’t a free pass to ignore fibroids—it’s an invitation to approach them with clearer eyes. For Chicago’s Latina community, that means demanding care that’s precise, accessible, and respectful of their unique needs. It means celebrating progress without letting up on the fight for better health outcomes. And it means recognizing that even as the data evolves, the goal remains the same: ensuring every woman, regardless of background, gets the care she deserves.

Ready to find trusted professionals? Browse our complete directory of top-rated women’s health experts in the Chicago area today.